Skip to main content
Erschienen in: Reactions Weekly 1/2013

01.08.2013 | Case report

Cisplatin/docetaxel/fluorouracil

Haemophagocytic lymphohistiocytosis (first report with docetaxel and fluorouracil) leading to refractory shock: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
  • First published case report
Literatur
Zurück zum Zitat Aryal MR, et al. Haemophagocytic lymphohistiocytosis mimicking septic shock after the initiation of chemotherapy for squamous cell sarcinoma of the neck. BMJ Case Reports 2013: [3 pages], No. 009651, 27 Jun 2013. Available from: URL: http://dx.doi.org/10.1136/bcr-2013-009651 - USA Aryal MR, et al. Haemophagocytic lymphohistiocytosis mimicking septic shock after the initiation of chemotherapy for squamous cell sarcinoma of the neck. BMJ Case Reports 2013: [3 pages], No. 009651, 27 Jun 2013. Available from: URL: http://​dx.​doi.​org/​10.​1136/​bcr-2013-009651 - USA
Metadaten
Titel
Cisplatin/docetaxel/fluorouracil
Haemophagocytic lymphohistiocytosis (first report with docetaxel and fluorouracil) leading to refractory shock: case report
Publikationsdatum
01.08.2013
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2013
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-013-5474-7

Weitere Artikel der Ausgabe 1/2013

Reactions Weekly 1/2013 Zur Ausgabe

Case report

Iopamidol

Case report

Oxaliplatin

Case report

Ampicillin

Case report

Propylthiouracil

Case report

Rifampicin